Home » Topics » BioWorld Science

BioWorld Science
RSS

Sunshine Lake Pharma patents new GNRHR antagonists

April 22, 2022

Janssen synthesizes new DHODH inhibitors

April 22, 2022

Asahi Kasei Pharma and Vernalis Group present new IRAK inhibitors

April 22, 2022

Cadila Healthcare patents viral nsp3 inhibitors

April 22, 2022

Incyte discloses new GTPase KRAS mutant inhibitors

April 22, 2022

Post viral infection, resting T-cell subtypes cooperate to drive neuroinflammation

April 22, 2022

M-1774 demonstrates potent antitumor activity both as monotherapy and in combination

April 22, 2022

MRT-2359 shows promise for Myc-driven solid tumors

April 22, 2022

Astrocyte-produced enzyme affects neuronal activity, stroke outcomes

April 21, 2022

KLS-13019 prevents the development of chemotherapy-induced peripheral neuropathy in rodents

April 21, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...